Registration No. 333-269132
(To Prospectus dated March 21, 2023)
| | |
Page
|
| |||
| | | | S-1 | | | |
| | | | S-2 | | | |
| | | | S-4 | | | |
| | | | S-5 | | | |
| | | | S-8 | | | |
| | | | S-9 | | | |
| | | | S-10 | | | |
| | | | S-11 | | | |
| | | | S-13 | | | |
| | | | S-13 | | | |
| | | | S-13 | | | |
| | | | S-14 | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 5 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 6 | | | |
| | | | 14 | | | |
| | | | 18 | | | |
| | | | 18 | | | |
| | | | 18 | | | |
| | | | 19 | | |
|
Assumed public offering price per share
|
| | | $ | 16.40 | | |
|
Net tangible book value per share as of September 30, 2024
|
| | | $ | 4.65 | | |
|
Increase in net tangible book value per share attributable to this offering
|
| | | $ | .77 | | |
|
Adjusted net tangible book value per share as of September 30, 2024, after giving effect to
this offering |
| | | $ | 5.42 | | |
|
Dilution per share to new investors purchasing shares in this offering
|
| | | $ | 10.98 | | |
Attn: Dr. Stefan Murry, Chief Financial Officer
13139 Jess Pirtle Blvd.
Sugar Land, TX 77478
(281) 295-1800
Preferred Stock
Warrants
Units
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 5 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 6 | | | |
| | | | | 14 | | | |
| | | | | 18 | | | |
| | | | | 18 | | | |
| | | | | 18 | | | |
| | | | | 19 | | |
Attn: Dr. Stefan Murry, Chief Financial Officer
13139 Jess Pirtle Blvd.
Sugar Land, TX 77478
(281) 295-1800